MeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, designed to enhance the management of patients with suspected ...
ANDOVER, Mass. & HAIFA, Israel, February 27, 2025--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the publication of three new peer-reviewed studies, reinforcing ...